IO BIOTECH ApS
CVR 36474483 · Private limited company (ApS) · In bankruptcy
IO BIOTECH ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. IO BIOTECH ApS went bankrupt on – 11.3 years after it was founded. 10 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2024) shows equity of DKK -6.6m and a net result of DKK -84.8m.
Bankruptcy
- Bankruptcy date
- Status
- In bankruptcy proceedings
- Age at bankruptcy
- 11.3 years
Company details
- CVR number
- 36474483
- Status
- In bankruptcy
- Company type
- Private limited company (ApS)
- Founded
- Address
- c/o COBIS, Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 2.8m
- Employees
- 12 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 1 of 10 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -9.9% |
| Current ratio | 88% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2024 | 2023 |
|---|---|---|
| Net profit | DKK -84.8m | DKK -76.6m |
| Equity | DKK -6.6m | DKK 18.2m |
| Total assets | DKK 67.0m | DKK 59.0m |
| Cash | DKK 12.8m | – |
| Short-term debt | DKK 73.6m | – |
| Avg. employees | 25 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2024 – 31 Dec 2024 | 178 | ||
| 1 Jan 2023 – 31 Dec 2023 | 127 | ||
| 1 Jan 2022 – 31 Dec 2022 | 182 | ||
| 1 Jan 2021 – 31 Dec 2021 | 180 | ||
| 1 Jan 2020 – 31 Dec 2020 | 201 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 140 | ||
| 1 Jan 2018 – 31 Dec 2018 | 128 | ||
| 1 Jan 2017 – 31 Dec 2017 | 129 | ||
| 1 Jan 2016 – 31 Dec 2016 | 115 | ||
| 23 Dec 2014 – 31 Dec 2015 | 145 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Bo Anders Ljungqvist | ||
| Board | Mai-Britt Zocca | ||
| Board | Hans Thalsgård Schambye | ||
| Board | Mads Hald Andersen | ||
| Board | Nanna Liebach Lüneborg | ||
| Board | Christian Ellebæk Elling | ||
| Board | Stephan Christgau | ||
| Board | Peter Hirth | ||
| Board | Claus Asbjørn Andersson | ||
| Board | Kathleen Sereda Glaub | ||
| Board | Emmanuelle Coutanceau | ||
| Board | Jack Bech Nielsen | ||
| Board | Priyanka Belawat | ||
| Board | Vanessa Malier | ||
| Owner (100%) | IO Biotech Inc. | Current | |
| Owner (10%) | Novo Holdings A/S | ||
| Owner (33%) | HALD ANDERSEN HOLDING ApS | ||
| Owner (10%) | THOR STRATEN HOLDING ApS | ||
| Owner (5%) | RQ SOLUTIONS ApS | ||
| Owner (10%) | ZOCCA CONSULTING ApS | ||
| Owner (15%) | Inge Marie Svane | ||
| Owner (25%) | Novo Holdings A/S | ||
| Owner (20%) | HALD ANDERSEN HOLDING ApS | ||
| Owner (5%) | THOR STRATEN HOLDING ApS | ||
| Owner (25%) | LUNDBECKFOND INVEST A/S | ||
| Owner (5%) | ZOCCA CONSULTING ApS | ||
| Owner (5%) | Inge Marie Svane | ||
| Owner (5%) | HALD ANDERSEN HOLDING ApS | ||
| Owner (20%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (33%) | Novo Holdings A/S | ||
| Owner (33%) | LUNDBECKFOND INVEST A/S | ||
| Owner (20%) | Novo Holdings A/S | ||
| Owner (25%) | LUNDBECKFOND INVEST A/S | ||
| Owner (15%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (5%) | HBM Healthcare Investments (Cayman) Ltd. | ||
| Owner (5%) | Avoro Life Sciences Fund LLC | ||
| Owner (5%) | Vivo Capital Fund IX, L.P. | ||
| Owner (10%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (20%) | LUNDBECKFOND INVEST A/S | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (5%) | SUNSTONE LIFE SCIENCE VENTURES FUND III K/S | ||
| Owner (10%) | HBM Healthcare Investments (Cayman) Ltd. | ||
| Owner (10%) | Vivo Capital Fund IX, L.P. | ||
| Owner (5%) | Avoro Life Sciences Fund LLC | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | JUSMEDICO ADVOKATANPARTSSELSKAB | Current |
Address history (0 moves)
| c/o COBIS, Ole Maaløes Vej 3, 2200 København N |
Employees per year
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
- ACCELERACE MANAGEMENT A/S Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about IO BIOTECH ApS
Has IO BIOTECH ApS gone bankrupt?
Yes. IO BIOTECH ApS went bankrupt on 8 April 2026.
Who is the auditor of IO BIOTECH ApS?
IO BIOTECH ApS most recently used EY Godkendt Revisionspartnerselskab.
When was IO BIOTECH ApS founded?
IO BIOTECH ApS was founded on 23 December 2014.
What is the equity of IO BIOTECH ApS?
Equity was DKK -6.6m according to the annual report for the period ending 31 December 2024.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.